

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | piRNA metabolic process (GO:0034587) | 7.16129286 |
| 2 | male meiosis (GO:0007140) | 6.30347205 |
| 3 | melanin biosynthetic process (GO:0042438) | 5.94783787 |
| 4 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 5.80962852 |
| 5 | synapsis (GO:0007129) | 5.65307436 |
| 6 | DNA methylation involved in gamete generation (GO:0043046) | 5.59405388 |
| 7 | melanin metabolic process (GO:0006582) | 5.38104283 |
| 8 | regulation of translational termination (GO:0006449) | 5.33962595 |
| 9 | secondary metabolite biosynthetic process (GO:0044550) | 5.18449267 |
| 10 | tachykinin receptor signaling pathway (GO:0007217) | 5.11447630 |
| 11 | regulation of uterine smooth muscle contraction (GO:0070472) | 4.62099557 |
| 12 | histone exchange (GO:0043486) | 4.26613185 |
| 13 | meiotic nuclear division (GO:0007126) | 4.18000263 |
| 14 | positive regulation of protein homodimerization activity (GO:0090073) | 4.13347101 |
| 15 | regulation of mitochondrial translation (GO:0070129) | 4.09421949 |
| 16 | regulation of oxidative phosphorylation (GO:0002082) | 4.09117511 |
| 17 | regulation of cellular respiration (GO:0043457) | 4.02986354 |
| 18 | chromatin remodeling at centromere (GO:0031055) | 3.88650497 |
| 19 | purine nucleobase biosynthetic process (GO:0009113) | 3.87143967 |
| 20 | neurotransmitter uptake (GO:0001504) | 3.80835450 |
| 21 | CENP-A containing nucleosome assembly (GO:0034080) | 3.79291192 |
| 22 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 3.65942009 |
| 23 | cellular response to nitric oxide (GO:0071732) | 3.57126712 |
| 24 | response to pheromone (GO:0019236) | 3.51071391 |
| 25 | male meiosis I (GO:0007141) | 3.36893211 |
| 26 | nucleobase biosynthetic process (GO:0046112) | 3.31449058 |
| 27 | cullin deneddylation (GO:0010388) | 3.29850422 |
| 28 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.25196904 |
| 29 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.25196904 |
| 30 | regulation of transcription from RNA polymerase I promoter (GO:0006356) | 3.24172339 |
| 31 | binding of sperm to zona pellucida (GO:0007339) | 3.23006829 |
| 32 | purine nucleotide salvage (GO:0032261) | 3.21456632 |
| 33 | proteasome assembly (GO:0043248) | 3.20876750 |
| 34 | regulation of phosphoprotein phosphatase activity (GO:0043666) | 3.16089489 |
| 35 | negative regulation of cell size (GO:0045792) | 3.13850921 |
| 36 | pigment biosynthetic process (GO:0046148) | 3.12329890 |
| 37 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.11990837 |
| 38 | deoxyribose phosphate catabolic process (GO:0046386) | 3.10846501 |
| 39 | positive regulation of response to oxidative stress (GO:1902884) | 3.09667116 |
| 40 | positive regulation of cellular response to oxidative stress (GO:1900409) | 3.09667116 |
| 41 | chromosome organization involved in meiosis (GO:0070192) | 3.09268228 |
| 42 | meiotic chromosome segregation (GO:0045132) | 3.08050965 |
| 43 | spermatid development (GO:0007286) | 3.07052817 |
| 44 | positive regulation of T cell cytokine production (GO:0002726) | 3.06471986 |
| 45 | DNA deamination (GO:0045006) | 3.05316189 |
| 46 | meiosis I (GO:0007127) | 3.02275289 |
| 47 | regulation of feeding behavior (GO:0060259) | 3.01994613 |
| 48 | mismatch repair (GO:0006298) | 2.99169119 |
| 49 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.97091517 |
| 50 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.95110680 |
| 51 | regulation of oxidative stress-induced neuron death (GO:1903203) | 2.94564004 |
| 52 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.92770860 |
| 53 | galactose catabolic process (GO:0019388) | 2.92396797 |
| 54 | protein deneddylation (GO:0000338) | 2.92017949 |
| 55 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.91309580 |
| 56 | acrosome reaction (GO:0007340) | 2.89310864 |
| 57 | protein K6-linked ubiquitination (GO:0085020) | 2.87498207 |
| 58 | IMP metabolic process (GO:0046040) | 2.86259182 |
| 59 | rRNA modification (GO:0000154) | 2.84370633 |
| 60 | replication fork processing (GO:0031297) | 2.84203664 |
| 61 | resolution of meiotic recombination intermediates (GO:0000712) | 2.83378672 |
| 62 | stress fiber assembly (GO:0043149) | 2.77850900 |
| 63 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.77542069 |
| 64 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.76915651 |
| 65 | ketone body metabolic process (GO:1902224) | 2.75263655 |
| 66 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.75041853 |
| 67 | protein K11-linked deubiquitination (GO:0035871) | 2.71025364 |
| 68 | ether lipid metabolic process (GO:0046485) | 2.70547241 |
| 69 | regulation of dopamine metabolic process (GO:0042053) | 2.68622707 |
| 70 | regulation of catecholamine metabolic process (GO:0042069) | 2.68622707 |
| 71 | polyamine biosynthetic process (GO:0006596) | 2.67876207 |
| 72 | IMP biosynthetic process (GO:0006188) | 2.67643037 |
| 73 | hepatocyte apoptotic process (GO:0097284) | 2.66789705 |
| 74 | glucosamine-containing compound catabolic process (GO:1901072) | 2.63830123 |
| 75 | histone H2A acetylation (GO:0043968) | 2.63507871 |
| 76 | nuclear pore complex assembly (GO:0051292) | 2.62869206 |
| 77 | sister chromatid cohesion (GO:0007062) | 2.62528791 |
| 78 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.62048825 |
| 79 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.62048825 |
| 80 | ribosome assembly (GO:0042255) | 2.61922119 |
| 81 | spliceosomal snRNP assembly (GO:0000387) | 2.59707589 |
| 82 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.59598371 |
| 83 | base-excision repair (GO:0006284) | 2.58904987 |
| 84 | negative regulation of ligase activity (GO:0051352) | 2.58826861 |
| 85 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.58826861 |
| 86 | histone mRNA metabolic process (GO:0008334) | 2.58669581 |
| 87 | DNA strand renaturation (GO:0000733) | 2.58285031 |
| 88 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.58064255 |
| 89 | base-excision repair, AP site formation (GO:0006285) | 2.57654799 |
| 90 | rRNA methylation (GO:0031167) | 2.57320447 |
| 91 | sperm-egg recognition (GO:0035036) | 2.57031416 |
| 92 | developmental pigmentation (GO:0048066) | 2.56544440 |
| 93 | pigment metabolic process (GO:0042440) | 2.55018585 |
| 94 | regulation of DNA endoreduplication (GO:0032875) | 2.54545107 |
| 95 | regulation of centriole replication (GO:0046599) | 2.54045185 |
| 96 | phenol-containing compound biosynthetic process (GO:0046189) | 2.52118984 |
| 97 | double-strand break repair via homologous recombination (GO:0000724) | 2.50120072 |
| 98 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.49491278 |
| 99 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.48317901 |
| 100 | recombinational repair (GO:0000725) | 2.47881589 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.16548189 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 5.33170338 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.11568162 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.40331577 |
| 5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.27826327 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.19804214 |
| 7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.06803515 |
| 8 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.06607485 |
| 9 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.96923722 |
| 10 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.83199599 |
| 11 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.68433060 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.67705640 |
| 13 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.41091176 |
| 14 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.40134084 |
| 15 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.28431402 |
| 16 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.26260374 |
| 17 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.24065477 |
| 18 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.18337221 |
| 19 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.15278793 |
| 20 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.06750394 |
| 21 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.05673741 |
| 22 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.99902571 |
| 23 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.87413778 |
| 24 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.86044045 |
| 25 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.82134254 |
| 26 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.78595339 |
| 27 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.77594989 |
| 28 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.73839758 |
| 29 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.73161379 |
| 30 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.67705253 |
| 31 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.66928817 |
| 32 | VDR_22108803_ChIP-Seq_LS180_Human | 1.65544042 |
| 33 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.65335404 |
| 34 | FUS_26573619_Chip-Seq_HEK293_Human | 1.63308238 |
| 35 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.63001527 |
| 36 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.61163498 |
| 37 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.59254659 |
| 38 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.55126340 |
| 39 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.54393290 |
| 40 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.52733680 |
| 41 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.48020933 |
| 42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.43879249 |
| 43 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.42752971 |
| 44 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.41458632 |
| 45 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.41381650 |
| 46 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.41227132 |
| 47 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.40504333 |
| 48 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.37421992 |
| 49 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.33339804 |
| 50 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.30850494 |
| 51 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.25975969 |
| 52 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.25033444 |
| 53 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.23346575 |
| 54 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.20820786 |
| 55 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.20112069 |
| 56 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.13737747 |
| 57 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.09834712 |
| 58 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.09326001 |
| 59 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.09241748 |
| 60 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08243675 |
| 61 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.07998276 |
| 62 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.07520718 |
| 63 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.07434206 |
| 64 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.07434206 |
| 65 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.03778447 |
| 66 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03676070 |
| 67 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.03111562 |
| 68 | NCOR_22424771_ChIP-Seq_293T_Human | 1.02302309 |
| 69 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.02021151 |
| 70 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.99128987 |
| 71 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.99056365 |
| 72 | GATA3_26560356_Chip-Seq_TH2_Human | 0.98684064 |
| 73 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.96724493 |
| 74 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.94484544 |
| 75 | EWS_26573619_Chip-Seq_HEK293_Human | 0.93989641 |
| 76 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.93510998 |
| 77 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.91050359 |
| 78 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.90745933 |
| 79 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.90510084 |
| 80 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.88010753 |
| 81 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.87616867 |
| 82 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87574527 |
| 83 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.87005886 |
| 84 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.86526984 |
| 85 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.85054335 |
| 86 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.84604455 |
| 87 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.84263275 |
| 88 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82645969 |
| 89 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82223945 |
| 90 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.81434143 |
| 91 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.81240762 |
| 92 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.81125259 |
| 93 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.80985559 |
| 94 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.80705906 |
| 95 | NFYB_21822215_ChIP-Seq_K562_Human | 0.80287540 |
| 96 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.80007135 |
| 97 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.79703817 |
| 98 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.78433124 |
| 99 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.77491072 |
| 100 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.76832804 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000372_irregular_coat_pigmentation | 6.91928339 |
| 2 | MP0002102_abnormal_ear_morphology | 5.44776521 |
| 3 | MP0005645_abnormal_hypothalamus_physiol | 3.87304369 |
| 4 | MP0005075_abnormal_melanosome_morpholog | 3.82621338 |
| 5 | MP0005410_abnormal_fertilization | 3.31468008 |
| 6 | MP0010094_abnormal_chromosome_stability | 3.22728807 |
| 7 | MP0003646_muscle_fatigue | 3.16100054 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.14464746 |
| 9 | MP0008877_abnormal_DNA_methylation | 3.05076758 |
| 10 | MP0005408_hypopigmentation | 2.50771626 |
| 11 | MP0003693_abnormal_embryo_hatching | 2.24584140 |
| 12 | MP0000015_abnormal_ear_pigmentation | 2.22063093 |
| 13 | MP0008057_abnormal_DNA_replication | 2.03743106 |
| 14 | MP0004147_increased_porphyrin_level | 1.97406567 |
| 15 | MP0005174_abnormal_tail_pigmentation | 1.90780991 |
| 16 | MP0004957_abnormal_blastocyst_morpholog | 1.87782585 |
| 17 | MP0006036_abnormal_mitochondrial_physio | 1.84969766 |
| 18 | MP0003136_yellow_coat_color | 1.82119976 |
| 19 | MP0008058_abnormal_DNA_repair | 1.82082994 |
| 20 | MP0003718_maternal_effect | 1.78667723 |
| 21 | MP0004885_abnormal_endolymph | 1.78602752 |
| 22 | MP0005646_abnormal_pituitary_gland | 1.72382568 |
| 23 | MP0003786_premature_aging | 1.70663660 |
| 24 | MP0001929_abnormal_gametogenesis | 1.70321465 |
| 25 | MP0006072_abnormal_retinal_apoptosis | 1.68917298 |
| 26 | MP0002132_abnormal_respiratory_system | 1.67745830 |
| 27 | MP0001188_hyperpigmentation | 1.61670714 |
| 28 | MP0005647_abnormal_sex_gland | 1.60270542 |
| 29 | MP0002160_abnormal_reproductive_system | 1.57856389 |
| 30 | MP0003111_abnormal_nucleus_morphology | 1.56841223 |
| 31 | MP0002396_abnormal_hematopoietic_system | 1.54581901 |
| 32 | MP0001905_abnormal_dopamine_level | 1.53260208 |
| 33 | MP0002095_abnormal_skin_pigmentation | 1.48221812 |
| 34 | MP0008004_abnormal_stomach_pH | 1.48084145 |
| 35 | MP0008007_abnormal_cellular_replicative | 1.47851036 |
| 36 | MP0003763_abnormal_thymus_physiology | 1.46543193 |
| 37 | MP0005171_absent_coat_pigmentation | 1.44415700 |
| 38 | MP0003698_abnormal_male_reproductive | 1.41880205 |
| 39 | MP0003315_abnormal_perineum_morphology | 1.40833195 |
| 40 | MP0005253_abnormal_eye_physiology | 1.37694148 |
| 41 | MP0002090_abnormal_vision | 1.36734848 |
| 42 | MP0002877_abnormal_melanocyte_morpholog | 1.36617355 |
| 43 | MP0000427_abnormal_hair_cycle | 1.29510762 |
| 44 | MP0004381_abnormal_hair_follicle | 1.28819310 |
| 45 | MP0000371_diluted_coat_color | 1.26380250 |
| 46 | MP0002210_abnormal_sex_determination | 1.21237024 |
| 47 | MP0002837_dystrophic_cardiac_calcinosis | 1.18891249 |
| 48 | MP0003950_abnormal_plasma_membrane | 1.16407427 |
| 49 | MP0006035_abnormal_mitochondrial_morpho | 1.16296212 |
| 50 | MP0001324_abnormal_eye_pigmentation | 1.16222575 |
| 51 | MP0002938_white_spotting | 1.13814171 |
| 52 | MP0008875_abnormal_xenobiotic_pharmacok | 1.11839479 |
| 53 | MP0009764_decreased_sensitivity_to | 1.08674287 |
| 54 | MP0005389_reproductive_system_phenotype | 1.08611673 |
| 55 | MP0002006_tumorigenesis | 1.07293715 |
| 56 | MP0005671_abnormal_response_to | 1.04800649 |
| 57 | MP0003077_abnormal_cell_cycle | 1.04073620 |
| 58 | MP0003878_abnormal_ear_physiology | 1.02289893 |
| 59 | MP0005377_hearing/vestibular/ear_phenot | 1.02289893 |
| 60 | MP0002166_altered_tumor_susceptibility | 0.98555318 |
| 61 | MP0001145_abnormal_male_reproductive | 0.95317731 |
| 62 | MP0000653_abnormal_sex_gland | 0.94655763 |
| 63 | MP0009840_abnormal_foam_cell | 0.90813662 |
| 64 | MP0008932_abnormal_embryonic_tissue | 0.88510809 |
| 65 | MP0000631_abnormal_neuroendocrine_gland | 0.87372807 |
| 66 | MP0001664_abnormal_digestion | 0.84859283 |
| 67 | MP0000383_abnormal_hair_follicle | 0.83182812 |
| 68 | MP0010678_abnormal_skin_adnexa | 0.81339992 |
| 69 | MP0004019_abnormal_vitamin_homeostasis | 0.77801547 |
| 70 | MP0000013_abnormal_adipose_tissue | 0.76096950 |
| 71 | MP0002161_abnormal_fertility/fecundity | 0.74057899 |
| 72 | MP0009785_altered_susceptibility_to | 0.71445229 |
| 73 | MP0002019_abnormal_tumor_incidence | 0.70965737 |
| 74 | MP0008995_early_reproductive_senescence | 0.70891988 |
| 75 | MP0005058_abnormal_lysosome_morphology | 0.70170609 |
| 76 | MP0002148_abnormal_hypersensitivity_rea | 0.68434686 |
| 77 | MP0002060_abnormal_skin_morphology | 0.65557368 |
| 78 | MP0001119_abnormal_female_reproductive | 0.65300250 |
| 79 | MP0003075_altered_response_to | 0.64747603 |
| 80 | MP0000313_abnormal_cell_death | 0.63916741 |
| 81 | MP0002075_abnormal_coat/hair_pigmentati | 0.63087308 |
| 82 | MP0005084_abnormal_gallbladder_morpholo | 0.62625761 |
| 83 | MP0003880_abnormal_central_pattern | 0.60695070 |
| 84 | MP0009765_abnormal_xenobiotic_induced | 0.60023558 |
| 85 | MP0002822_catalepsy | 0.58543101 |
| 86 | MP0004782_abnormal_surfactant_physiolog | 0.58534477 |
| 87 | MP0005451_abnormal_body_composition | 0.56383208 |
| 88 | MP0001984_abnormal_olfaction | 0.55056410 |
| 89 | MP0003172_abnormal_lysosome_physiology | 0.54170165 |
| 90 | MP0005391_vision/eye_phenotype | 0.53687100 |
| 91 | MP0003137_abnormal_impulse_conducting | 0.52670771 |
| 92 | MP0003011_delayed_dark_adaptation | 0.52582210 |
| 93 | MP0003436_decreased_susceptibility_to | 0.52196177 |
| 94 | MP0000703_abnormal_thymus_morphology | 0.51616044 |
| 95 | MP0000358_abnormal_cell_content/ | 0.50824206 |
| 96 | MP0003252_abnormal_bile_duct | 0.50339014 |
| 97 | MP0003186_abnormal_redox_activity | 0.50326089 |
| 98 | MP0001293_anophthalmia | 0.49346453 |
| 99 | MP0010234_abnormal_vibrissa_follicle | 0.49336640 |
| 100 | MP0001963_abnormal_hearing_physiology | 0.47948343 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.67494526 |
| 2 | Dyschromatopsia (HP:0007641) | 4.54358868 |
| 3 | Aplasia/Hypoplasia of the macula (HP:0008059) | 4.01169363 |
| 4 | Poor head control (HP:0002421) | 3.90764902 |
| 5 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 3.71965632 |
| 6 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.64114399 |
| 7 | B lymphocytopenia (HP:0010976) | 3.45230068 |
| 8 | Abnormality of B cell number (HP:0010975) | 3.12899172 |
| 9 | Type I transferrin isoform profile (HP:0003642) | 3.12773209 |
| 10 | Median cleft lip (HP:0000161) | 3.06653525 |
| 11 | Fibular hypoplasia (HP:0003038) | 3.05239835 |
| 12 | Abnormal protein glycosylation (HP:0012346) | 3.05082670 |
| 13 | Abnormal glycosylation (HP:0012345) | 3.05082670 |
| 14 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.05082670 |
| 15 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.05082670 |
| 16 | Increased hepatocellular lipid droplets (HP:0006565) | 3.01174086 |
| 17 | Lipid accumulation in hepatocytes (HP:0006561) | 3.00084025 |
| 18 | Stomatitis (HP:0010280) | 2.99830924 |
| 19 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.98546395 |
| 20 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.98546395 |
| 21 | Acute necrotizing encephalopathy (HP:0006965) | 2.98015443 |
| 22 | Degeneration of anterior horn cells (HP:0002398) | 2.93116090 |
| 23 | Abnormality of the anterior horn cell (HP:0006802) | 2.93116090 |
| 24 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.88677996 |
| 25 | IgM deficiency (HP:0002850) | 2.83802629 |
| 26 | Abnormality of chromosome stability (HP:0003220) | 2.80026793 |
| 27 | Blue irides (HP:0000635) | 2.78479666 |
| 28 | Progressive macrocephaly (HP:0004481) | 2.77578562 |
| 29 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.76881573 |
| 30 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.75369549 |
| 31 | Hyperglycinemia (HP:0002154) | 2.75360681 |
| 32 | Limb dystonia (HP:0002451) | 2.74602792 |
| 33 | Clumsiness (HP:0002312) | 2.70261544 |
| 34 | Chromsome breakage (HP:0040012) | 2.69392429 |
| 35 | Acute encephalopathy (HP:0006846) | 2.67663232 |
| 36 | Ragged-red muscle fibers (HP:0003200) | 2.65205948 |
| 37 | Constricted visual fields (HP:0001133) | 2.63683569 |
| 38 | Hypoplasia of the uterus (HP:0000013) | 2.61883783 |
| 39 | Cutaneous melanoma (HP:0012056) | 2.59986339 |
| 40 | Decreased central vision (HP:0007663) | 2.59590274 |
| 41 | Ocular albinism (HP:0001107) | 2.58945308 |
| 42 | Abnormal auditory evoked potentials (HP:0006958) | 2.57137828 |
| 43 | Abnormality of the fovea (HP:0000493) | 2.56611249 |
| 44 | Hypopigmentation of the fundus (HP:0007894) | 2.53968697 |
| 45 | Generalized hypopigmentation (HP:0007513) | 2.52977749 |
| 46 | Increased CSF lactate (HP:0002490) | 2.49624786 |
| 47 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.48458496 |
| 48 | Amyotrophic lateral sclerosis (HP:0007354) | 2.46781413 |
| 49 | Testicular atrophy (HP:0000029) | 2.46566092 |
| 50 | Dysphonia (HP:0001618) | 2.46510021 |
| 51 | IgG deficiency (HP:0004315) | 2.45927380 |
| 52 | Increased intramyocellular lipid droplets (HP:0012240) | 2.42562885 |
| 53 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.39874130 |
| 54 | Ependymoma (HP:0002888) | 2.37561954 |
| 55 | Mitochondrial inheritance (HP:0001427) | 2.37227718 |
| 56 | Iris hypopigmentation (HP:0007730) | 2.36371714 |
| 57 | White forelock (HP:0002211) | 2.27724368 |
| 58 | Retinal dysplasia (HP:0007973) | 2.25643012 |
| 59 | Resting tremor (HP:0002322) | 2.24704667 |
| 60 | Hypokinesia (HP:0002375) | 2.23606915 |
| 61 | Tongue fasciculations (HP:0001308) | 2.20745712 |
| 62 | Renal Fanconi syndrome (HP:0001994) | 2.20208802 |
| 63 | Patchy hypopigmentation of hair (HP:0011365) | 2.18012727 |
| 64 | Prostate neoplasm (HP:0100787) | 2.17539041 |
| 65 | Abnormal spermatogenesis (HP:0008669) | 2.17259566 |
| 66 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 2.17140401 |
| 67 | Cerebral edema (HP:0002181) | 2.16439621 |
| 68 | Abnormal lung lobation (HP:0002101) | 2.13329702 |
| 69 | Hypoplasia of the fovea (HP:0007750) | 2.10316956 |
| 70 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.10316956 |
| 71 | Reduced antithrombin III activity (HP:0001976) | 2.07780412 |
| 72 | Abnormality of the prostate (HP:0008775) | 2.07493081 |
| 73 | Facial diplegia (HP:0001349) | 2.05824765 |
| 74 | Increased serum lactate (HP:0002151) | 2.05681409 |
| 75 | Increased muscle lipid content (HP:0009058) | 2.05480296 |
| 76 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.04543226 |
| 77 | Horizontal nystagmus (HP:0000666) | 2.04003235 |
| 78 | Colon cancer (HP:0003003) | 2.02208837 |
| 79 | Freckling (HP:0001480) | 2.01993105 |
| 80 | Abnormality of serum amino acid levels (HP:0003112) | 2.00130532 |
| 81 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.97884447 |
| 82 | Tubulointerstitial nephritis (HP:0001970) | 1.97491758 |
| 83 | Sensory axonal neuropathy (HP:0003390) | 1.94920092 |
| 84 | Abnormality of the ileum (HP:0001549) | 1.94807103 |
| 85 | CNS hypomyelination (HP:0003429) | 1.93632040 |
| 86 | Meckel diverticulum (HP:0002245) | 1.93350214 |
| 87 | Congenital stationary night blindness (HP:0007642) | 1.93105216 |
| 88 | Upper motor neuron abnormality (HP:0002127) | 1.91217381 |
| 89 | Congenital sensorineural hearing impairment (HP:0008527) | 1.90539772 |
| 90 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.88988353 |
| 91 | Menstrual irregularities (HP:0000858) | 1.88668636 |
| 92 | Lactic acidosis (HP:0003128) | 1.88403955 |
| 93 | Hepatocellular necrosis (HP:0001404) | 1.87759267 |
| 94 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.87269183 |
| 95 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.84622930 |
| 96 | Bifid tongue (HP:0010297) | 1.82377892 |
| 97 | Exertional dyspnea (HP:0002875) | 1.78449499 |
| 98 | Hamartoma of the eye (HP:0010568) | 1.77537446 |
| 99 | Muscle fibrillation (HP:0010546) | 1.74491694 |
| 100 | Microretrognathia (HP:0000308) | 1.72749490 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCYL2 | 4.23258789 |
| 2 | ZAK | 4.18768954 |
| 3 | PINK1 | 3.75662772 |
| 4 | EIF2AK1 | 3.64488528 |
| 5 | TLK1 | 2.84783497 |
| 6 | FGR | 2.72355145 |
| 7 | EIF2AK3 | 2.57808947 |
| 8 | PTK2B | 2.38841874 |
| 9 | MET | 2.30560707 |
| 10 | MST1R | 2.19986337 |
| 11 | NEK1 | 2.17441459 |
| 12 | WEE1 | 2.01496896 |
| 13 | TRIM28 | 1.99987862 |
| 14 | NUAK1 | 1.90959490 |
| 15 | TESK2 | 1.86249311 |
| 16 | PLK2 | 1.78576303 |
| 17 | MARK3 | 1.76524381 |
| 18 | MAP3K12 | 1.71452054 |
| 19 | MKNK1 | 1.70726457 |
| 20 | VRK2 | 1.69298209 |
| 21 | MATK | 1.64087037 |
| 22 | PLK3 | 1.55442295 |
| 23 | TAF1 | 1.44520941 |
| 24 | BMPR1B | 1.43295999 |
| 25 | PLK4 | 1.40415224 |
| 26 | MAPKAPK5 | 1.39421336 |
| 27 | ATR | 1.35196547 |
| 28 | NME2 | 1.33843061 |
| 29 | TESK1 | 1.32671664 |
| 30 | WNK4 | 1.30424099 |
| 31 | TSSK6 | 1.29456187 |
| 32 | MYLK | 1.28701181 |
| 33 | LIMK1 | 1.28222831 |
| 34 | VRK1 | 1.26555690 |
| 35 | GRK6 | 1.26264697 |
| 36 | ADRBK2 | 1.25543271 |
| 37 | ACVR1B | 1.25120973 |
| 38 | MKNK2 | 1.24594274 |
| 39 | PASK | 1.21895845 |
| 40 | RPS6KA5 | 1.21853005 |
| 41 | BMPR2 | 1.19511565 |
| 42 | CDC7 | 1.19470993 |
| 43 | WNK3 | 1.12802674 |
| 44 | CDK3 | 1.09019516 |
| 45 | PNCK | 1.05990466 |
| 46 | TEC | 1.05630568 |
| 47 | STK3 | 1.02129074 |
| 48 | MAP3K14 | 1.00752023 |
| 49 | CHEK2 | 1.00439774 |
| 50 | MAP4K2 | 1.00156486 |
| 51 | CSNK1G3 | 0.98423298 |
| 52 | KIT | 0.93123477 |
| 53 | TAOK2 | 0.93101162 |
| 54 | SRPK1 | 0.92357446 |
| 55 | KDR | 0.91027431 |
| 56 | ITK | 0.90990871 |
| 57 | MAP2K7 | 0.89430906 |
| 58 | EIF2AK2 | 0.87636486 |
| 59 | FRK | 0.87578535 |
| 60 | ERBB3 | 0.87050802 |
| 61 | MST4 | 0.86606001 |
| 62 | DAPK1 | 0.82956714 |
| 63 | PLK1 | 0.78934949 |
| 64 | BCKDK | 0.78246119 |
| 65 | CSNK1A1L | 0.77006991 |
| 66 | GRK5 | 0.75931418 |
| 67 | NEK2 | 0.72963469 |
| 68 | TTK | 0.71017522 |
| 69 | CSF1R | 0.66869387 |
| 70 | CSNK1G2 | 0.66264893 |
| 71 | ADRBK1 | 0.64910497 |
| 72 | STK38L | 0.60901810 |
| 73 | CSNK1G1 | 0.59898463 |
| 74 | ATM | 0.58293499 |
| 75 | AKT3 | 0.57111528 |
| 76 | TNIK | 0.56762965 |
| 77 | BUB1 | 0.52343550 |
| 78 | STK16 | 0.51666411 |
| 79 | CDK7 | 0.47400886 |
| 80 | TAOK3 | 0.44557783 |
| 81 | TRPM7 | 0.41409644 |
| 82 | CDK19 | 0.38619076 |
| 83 | WNK1 | 0.38315322 |
| 84 | IKBKB | 0.38066628 |
| 85 | EGFR | 0.35987391 |
| 86 | CDK8 | 0.34762041 |
| 87 | CSNK2A1 | 0.33964821 |
| 88 | RIPK4 | 0.33782263 |
| 89 | LATS1 | 0.32795063 |
| 90 | TBK1 | 0.32749412 |
| 91 | FES | 0.30547099 |
| 92 | AURKB | 0.30501675 |
| 93 | CHEK1 | 0.30490158 |
| 94 | CDK9 | 0.29017698 |
| 95 | IGF1R | 0.28716700 |
| 96 | BTK | 0.27891716 |
| 97 | GRK1 | 0.27622271 |
| 98 | CSNK1A1 | 0.26615060 |
| 99 | PRKCQ | 0.25562662 |
| 100 | MAP2K2 | 0.25553280 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.60717292 |
| 2 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 3.34285414 |
| 3 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.05664780 |
| 4 | Protein export_Homo sapiens_hsa03060 | 3.01163593 |
| 5 | Homologous recombination_Homo sapiens_hsa03440 | 2.70205076 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.69960081 |
| 7 | Base excision repair_Homo sapiens_hsa03410 | 2.38954576 |
| 8 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.13289559 |
| 9 | Asthma_Homo sapiens_hsa05310 | 2.01835122 |
| 10 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.00948555 |
| 11 | RNA transport_Homo sapiens_hsa03013 | 1.99842086 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.97845745 |
| 13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.97371285 |
| 14 | DNA replication_Homo sapiens_hsa03030 | 1.95295815 |
| 15 | Mismatch repair_Homo sapiens_hsa03430 | 1.94712450 |
| 16 | Legionellosis_Homo sapiens_hsa05134 | 1.94135299 |
| 17 | Parkinsons disease_Homo sapiens_hsa05012 | 1.84577488 |
| 18 | Spliceosome_Homo sapiens_hsa03040 | 1.73668842 |
| 19 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.71328446 |
| 20 | Basal transcription factors_Homo sapiens_hsa03022 | 1.66857117 |
| 21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.64478086 |
| 22 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.62929037 |
| 23 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.55635952 |
| 24 | RNA polymerase_Homo sapiens_hsa03020 | 1.52171233 |
| 25 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.37715586 |
| 26 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.37162962 |
| 27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.32103043 |
| 28 | RNA degradation_Homo sapiens_hsa03018 | 1.31552961 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.31443962 |
| 30 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.23982049 |
| 31 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.23335653 |
| 32 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.23070509 |
| 33 | Apoptosis_Homo sapiens_hsa04210 | 1.22177154 |
| 34 | Allograft rejection_Homo sapiens_hsa05330 | 1.22006854 |
| 35 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.17394415 |
| 36 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.16488211 |
| 37 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.15699520 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.13943001 |
| 39 | Cell cycle_Homo sapiens_hsa04110 | 1.10170589 |
| 40 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.10081706 |
| 41 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.06101641 |
| 42 | Purine metabolism_Homo sapiens_hsa00230 | 1.06001554 |
| 43 | Viral myocarditis_Homo sapiens_hsa05416 | 1.05476189 |
| 44 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.04878313 |
| 45 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.02468279 |
| 46 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.02135878 |
| 47 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.99128983 |
| 48 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.97251250 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.97246649 |
| 50 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.95925882 |
| 51 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.95561882 |
| 52 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.95319166 |
| 53 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.94728277 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.94201124 |
| 55 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.93403828 |
| 56 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.92522366 |
| 57 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.89389272 |
| 58 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.89141076 |
| 59 | Phagosome_Homo sapiens_hsa04145 | 0.87328222 |
| 60 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.86522038 |
| 61 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.83539418 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82391651 |
| 63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.80209290 |
| 64 | Phototransduction_Homo sapiens_hsa04744 | 0.79281477 |
| 65 | Huntingtons disease_Homo sapiens_hsa05016 | 0.79273666 |
| 66 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.76724014 |
| 67 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.74632503 |
| 68 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.72848828 |
| 69 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.72095658 |
| 70 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.70727198 |
| 71 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.69652894 |
| 72 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69377629 |
| 73 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.68213592 |
| 74 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.68164746 |
| 75 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.67867828 |
| 76 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.64503138 |
| 77 | Alzheimers disease_Homo sapiens_hsa05010 | 0.62247988 |
| 78 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.62013823 |
| 79 | Peroxisome_Homo sapiens_hsa04146 | 0.60527258 |
| 80 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.59527633 |
| 81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.56438574 |
| 82 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.54612350 |
| 83 | Salmonella infection_Homo sapiens_hsa05132 | 0.52495848 |
| 84 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.51573429 |
| 85 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.49196495 |
| 86 | Olfactory transduction_Homo sapiens_hsa04740 | 0.46619050 |
| 87 | Alcoholism_Homo sapiens_hsa05034 | 0.45533433 |
| 88 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.45435097 |
| 89 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44910039 |
| 90 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.44479560 |
| 91 | Other glycan degradation_Homo sapiens_hsa00511 | 0.42685770 |
| 92 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.42657742 |
| 93 | Influenza A_Homo sapiens_hsa05164 | 0.41915441 |
| 94 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.41681373 |
| 95 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.40464331 |
| 96 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.40289753 |
| 97 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.39655889 |
| 98 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.38859178 |
| 99 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.38551299 |
| 100 | Measles_Homo sapiens_hsa05162 | 0.37478239 |

